In recent years, network meta-analyses have been increasingly carried out to inform clinical guidelines and policy. This approach is under…
Digital innovations in mental health offer great potential, but present unique challenges. Using a consensus development panel approach, an expert,…
Question Randomised controlled trials assessing treatments for anxiety, obsessive-compulsive and stress-related disorders often present high placebo response rates in placebo…
Background Blinding of randomised controlled trials (RCTs) is very important for the accurate assessment of drug efficacy. Without proper blinding,…
It has become increasingly apparent that rapidly available information about the occurrence of suicides is needed, particularly to support suicide…
Background Cut-offs on self-report depression screening tools are designed to identify many more people than those who meet criteria for…
Background Hundreds of randomised controlled trials and dozens of meta-analyses have examined psychotherapies for depression—yet not all points in the…
Background Cue reactivity, the enhanced sensitivity to conditioned cues, is associated with habitual and compulsive alcohol consumption. However, most previous…
Welcome to BMJ Mental Health. In January 2023, Evidence-Based Mental Health (EBMH) has changed its name to BMJ Mental Health,…
Background Cognitive–behavioural therapy (CBT) and counselling for depression (CfD) are recommended first-line treatments for depression. While they approach change differently,…